mHealth and Home Monitoring is the eighth consecutive
report from Berg Insight that gives first-hand insights into the
adoption of wireless solutions for health monitoring.
This strategic research report from Berg Insight provides
you with 280 pages of unique business intelligence including
5-year industry forecasts and expert commentary on which to
base your business decisions.
This report will allow you to:
Profit from 40 new executive interviews with market leading
Learn about key home health monitoring devices and services.
Study the strategies of 124 key players in the mHealth
Understand the dynamics of the health monitoring market
in Europe and North America.
Comprehend how wireless technology can become
seamlessly integrated with medical devices.
Evaluate the business opportunities in the emerging
Predict future market and technology developments.
This report answers the following questions:
Which medical conditions offer the best potential for wireless
health monitoring solutions?
Who are the leading providers of connected medical devices?
What are the mHealth strategies of medical device vendors
and pharmaceutical companies?
Which are the general technology trends for home health
What initiatives have been taken by the leading players in the
telecom and IT industries?
How can connectivity redefine the use cases of medical
devices and the value propositions to patients and other
What are the market shares of the top 5 integrated telehealth
Why are smartphone applications so significant for the
How can healthcare providers and payers benefit from
The number of remotely monitored patients grew by 44 percent to 7.1 million in 2016 as the
market entered a growth phase fuelled by rising market acceptance in several key verticals.
This number includes all patients enrolled in mHealth care programs in which connected
medical devices are used as a part of the care regimen. Connected medical devices used for
various forms of personal health tracking are not included in this figure. Berg Insight
estimates that the number of remotely monitored patients will grow at a compound annual
growth rate (CAGR) of 47.9 percent to reach 50.2 million by 2021. Cellular connectivity has
already replaced PSTN as the de-facto standard communication technology for most types of
connected home medical monitoring devices and will account for 25.2 million connections in
2021. Using patients’ own mobile devices as health hubs is now becoming a viable alternative
for remote patient monitoring. BYOD connectivity will be preferred by select patient groups
and will be used for the remote monitoring of 22.9 million patients in 2021.
Berg Insight estimates that revenues for remote patient monitoring (RPM) solutions reached
€_7.5 billion in 2016, including revenues from medical monitoring devices, mHealth
connectivity solutions, care delivery platforms and mHealth care programs. RPM revenues
are expected to grow at a CAGR of 33.8 percent between 2016 and 2021 to reach € 32.4
billion at the end of the forecast period. Connected medical devices accounted for 67.5
percent of total RPM revenues in 2016. However, revenues for mHealth connectivity solutions,
care delivery platforms and mHealth care programs are growing at a faster rate and will
account for 51.3 percent of total revenues in 2021, up from just 32.5 percent in 2016.
There is a strong trend towards incorporating more connectivity in medical devices and
pharmaceuticals in order to enable new services and value propositions. Implantable cardiac
rhythm management (CRM) has traditionally been the largest market segment, led by
companies such as Medtronic, Biotronik and St Jude Medical (now Abbott) that included
connectivity in CRM solutions more than a decade ago. However, the sleep therapy segment
is growing at the fastest rate and surpassed CRM in 2016. The number of remotely monitored
sleep therapy patients grew by 70 percent in 2016, with market growth mainly driven by the
vendor ResMed that has made connected healthcare a cornerstone of its strategy. Berg
Insight predicts that three of the fastest growing market segments in the next five years will be
glucose monitoring, air flow monitoring and connected pharmaceuticals. Today, the leading
connected healthcare players in these segments include forward-thinking incumbents as well
as innovative new entrants such as AstraZeneca, Dexcom, Merck Group, Novartis, Propeller
Health, Proteus Digital Health, Roche, Sanofi, Voluntis and WellDoc.
Care delivery platforms and mHealth connectivity solutions are two of the most rapidly
developing parts of the mHealth technology value chain. Care delivery platforms are software
solutions that enable the remote delivery of healthcare services and allow care efforts to be
coordinated between patients, various professional caregivers and other stakeholders such
as the patient’s family. Care delivery platforms will be instrumental for engaging patients in
their own care and delivering remote monitoring services to a large number of people in a
cost efficient way. There are various types of care delivery platforms available on the market.
General-purpose platforms can be adapted to a wide variety of use cases and are often used
as the foundation for developing therapeutic area specific mHealth products. Companies that
specialize in this area include BePatient, Exco InTouch, Medixine, OpenTeleHealth and Vivify
Health. mHealth connectivity solutions include products and services that are used for
collecting data from medical monitoring devices, transmitting this data to caregivers and
enabling the data to be used by care delivery platforms. The leading players include
Qualcomm Life, eDevice/iHealth, Tactio Health, Validic and MedM.
Health-related apps and devices are generating potentially huge amounts of data. When the
line between medical devices and health gadgets become blurred, traditional as well as
startup companies try to position themselves as important stakeholders in the ecosystem for
mHealth data. National PHR systems, device manufacturing companies, independent app
producers and tech giants such as Google, Apple, Microsoft are some common options for
data storage. One trend is to share data in third party clouds, exemplified by Glooko that
allows people suffering from diabetes to download their glucose readings to their mobile
devices, regardless of the brand of the glucose reading device. Important for end-users,
doctors and care giving institutions is to choose a place where as many standards as
possible are followed and where it is as easy as possible to export the data.
Johan Fagerberg is co-founder and an experienced
analyst with a Master’s degree in Electrical Engineering from
Chalmers University of Technology. He has during the past
20 years published numerous articles and reports about
Anders Frick is a Senior Analyst with a Master’s degree
in Media Technology from Linköping University and an MBA
degree in Technology Management from National Chiao
Tung University. His areas of expertise include mHealth and
smart homes markets.
offers premier business intelligence to
the telecom industry. We produce concise reports providing
key facts and strategic insights about pivotal developments
in our focus areas. Berg Insight also offers detailed market
forecast databases and advisory services. Our vision is to be
the most valuable source of intelligence for our customers.